Vimarsana
Biggest News Aggregation in the World

Page 10 - Alligator Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alligator Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alligator Bioscience Today - Breaking & Trending Today

Notice of extraordinary general meeting in Alligator Bioscience AB - Vimarsana News

Notice of extraordinary general meeting in Alligator Bioscience AB

/PRNewswire/ -- The shareholders of Alligator Bioscience AB, Reg. No. 556597-8201 ("Alligator"), are invited to the extraordinary general meeting to be held on...

Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation - Vimarsana News

Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation

/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license agreement...

Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy - Vimarsana News

Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy

/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the scientific journal Expert Opinion on Biological Therapy has published...

Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021 - Vimarsana News

Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021

/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the annual general meeting was held in the company this day. In light of...

Targinta recruits Per Norlén as CEO - Vimarsana News

Targinta recruits Per Norlén as CEO

2021-05-21 08:40 Xintela meddelar idag att bolaget har erhållit tillstånd från Läkemedelsverket att producera cellterapiprodukter, så kallade avancerade terapiläkemedel (ATMPs), i den egna GMP-anläggningen. 2021-05-21 08:40 Xintela announces today that the company has received permission from the Medical Products Agency to produce cell therapy products, so-called advanced therapy drugs (ATMPs), in its own GMP facility. 2021-05-20 11:40 Xintela tillkännager idag att bolaget ska utveckla sin stamcellsprodukt XSTEM® för behandling av svårläkta (kroniska) sår. I samarbete med Bränns...